{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:53:42Z","timestamp":1791431622365,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.drugalcdep.2025.112769","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T02:43:36Z","timestamp":1750733016000},"page":"112769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Mirtazapine reduces hypothetical methamphetamine demand in humans"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-8558","authenticated-orcid":false,"given":"Craig R.","family":"Rush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-5317","authenticated-orcid":false,"given":"Glenn-Milo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-7206","authenticated-orcid":false,"given":"Vanessa M.","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2161-7170","authenticated-orcid":false,"given":"Annie","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-6530","authenticated-orcid":false,"given":"Jesse","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xochitl","family":"Luna Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Shoptaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-6570","authenticated-orcid":false,"given":"Phillip O.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2025.112769_bib1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00213-023-06334-6","article-title":"The Blinded-Dose Purchase Task: assessing hypothetical demand based on cocaine, methamphetamine, and alcohol administration","volume":"240","author":"Berry","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib2","unstructured":"CDC 2024 Understanding the Opioid Overdose Epidemic. \u3008https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html\u3009."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib3","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/add.14755","article-title":"Pharmacotherapy for methamphetamine\/amphetamine use disorder-a systematic review and meta-analysis","volume":"114","author":"Chan","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamapsychiatry.2019.3655","article-title":"Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized clinical trial","volume":"77","author":"Coffin","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib5","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","article-title":"Mirtazapine to reduce methamphetamine use: a randomized controlled trial","volume":"68","author":"Colfax","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","article-title":"The role of human drug self-administration procedures in the development of medications","volume":"96","author":"Comer","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2004.01.018","article-title":"Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex","volume":"487","author":"Devoto","year":"2004","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/JCP.0000000000000511","article-title":"Safety of intravenous methamphetamine administration during ibudilast treatment","volume":"36","author":"DeYoung","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00639-7","article-title":"Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity","volume":"406","author":"Fleckenstein","year":"2000","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(98)00223-7","article-title":"Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission","volume":"51","author":"Haddjeri","year":"1998","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1300\/J082v41n02_02","article-title":"A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men","volume":"41","author":"Halkitis","year":"2001","journal-title":"J. Homosex"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130100738","article-title":"Methamphetamine self-administration by humans","volume":"157","author":"Hart","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14688","article-title":"Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction","volume":"1508","author":"Jones","year":"2022","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12963-025-00364-2","article-title":"How much missing data is too much to impute for longitudinal health indicators? A preliminary guideline for the choice of the extent of missing proportion to impute with multiple imputation by chained equations","volume":"23","author":"Junaid","year":"2025","journal-title":"Popul Health Metr."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib17","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","article-title":"Methamphetamine use and cardiovascular disease","volume":"39","author":"Kevil","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1360-0443.2011.03706.x","article-title":"Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans","volume":"107","author":"Kirkpatrick","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26544","article-title":"Association of methamphetamine and opioid use with nonfatal overdose in rural communities","volume":"5","author":"Korthuis","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/nedt.1.1.59.52296","article-title":"Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients","volume":"1","author":"Lavergne","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.drugalcdep.2018.06.038","article-title":"Pharmacotherapy for amphetamine dependence: a systematic review","volume":"191","author":"Lee","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib22","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/add.16093","article-title":"Clinical management of psychostimulant withdrawal: review of the evidence","volume":"118","author":"Li","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/adb.12592","article-title":"Validation of a behavioral economic purchase task for assessing drug abuse liability","volume":"24","author":"MacKillop","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/JCP.0000000000000488","article-title":"Separate and combined effects of naltrexone and extended-release alprazolam on the reinforcing, subject-rated, and cardiovascular effects of methamphetamine","volume":"36","author":"Marks","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","article-title":"The drug effects questionnaire: psychometric support across three drug types","volume":"227","author":"Morean","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109295","article-title":"Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: a systematic review and meta-analysis","volume":"232","author":"Naji","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00213-005-0102-8","article-title":"Safety of intravenous methamphetamine administration during treatment with bupropion","volume":"182","author":"Newton","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib29","unstructured":"NIDA 2024 Drug Overdose Deaths: Facts and Figures. \u3008https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates#Fig2\u3009."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pbb.2016.09.009","article-title":"Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine","volume":"150-151","author":"Pike","year":"2016","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","article-title":"Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis","volume":"80","author":"Potvin","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib32","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/npp.2015.83","article-title":"The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study","volume":"40","author":"Ray","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2017.08.038","article-title":"Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine","volume":"181","author":"Reynolds","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/ADM.0000000000000001","article-title":"Characteristics and impact of methamphetamine use in patients with chronic hepatitis C","volume":"8","author":"Riley","year":"2014","journal-title":"J. Addict. Med"},{"key":"10.1016\/j.drugalcdep.2025.112769_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108413","article-title":"Topiramate-phentermine combinations reduce cocaine self-administration in humans","volume":"218","author":"Rush","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0b013e3181d21967","article-title":"Cocaine choice in humans during D-amphetamine maintenance","volume":"30","author":"Rush","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173466","article-title":"Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans","volume":"220","author":"Stoops","year":"2022","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/FBP.0000000000000731","article-title":"Use of drug purchase tasks in medications development research: orexin system regulation of cocaine and drug demand","volume":"34","author":"Strickland","year":"2023","journal-title":"Behav. Pharm."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200038060-00001","article-title":"Clinical pharmacokinetics of mirtazapine","volume":"38","author":"Timmer","year":"2000","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw029","article-title":"Subjective and cardiovascular effects of intravenous methamphetamine during perindopril maintenance: a randomized, double-blind, placebo-controlled human laboratory study","volume":"19","author":"Verrico","year":"2016","journal-title":"Int J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2025.112769_bib41","first-page":"13","article-title":"Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence","volume":"2","author":"Zorick","year":"2010","journal-title":"J. Exp. Pharm."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:16:25Z","timestamp":1760591785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625002224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"alternative-id":["S0376871625002224"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112769","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mirtazapine reduces hypothetical methamphetamine demand in humans","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112769"}}